SUNZEN

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2021

SUNZEN BIOTECH BERHAD

Financial Year End 31 Dec 2021
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2021
The figures have not been audited
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2021
30 Sep 2020
30 Sep 2021
30 Sep 2020
$$'000
$$'000
$$'000
$$'000
1 Revenue
17,445
20,358
61,449
54,378
2 Profit/(loss) before tax
520
131
1,635
-4,879
3 Profit/(loss) for the period
158
53
808
-4,822
4 Profit/(loss) attributable to ordinary equity holders of the parent
71
-383
31
-4,647
5 Basic earnings/(loss) per share (Subunit)
0.01
-0.07
0.01
-0.88
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1700
0.1700

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name SUNZEN BIOTECH BERHAD
Stock Name SUNZEN
Date Announced 24 Nov 2021
Category Financial Results
Reference Number FRA-17112021-00026